Videre til indhold. |
Søren Schwartz SørensenMD, DMScResponsible forsections 3133/3134
Susanne BroMD, PhD, DMScResponsible for the outpatient department
Thomas Elung-JensenMD, PhDResponsible for peritoneal dialysis
Inge EidemakMD, PhDResponsible for haemodialysis H 5101/5102
Søren LadefogedMDResponsible for hemodialysis Frederiksberg Hospital
Martin EgfjordMD, DMSc, LecturerResponsible for the specialist training programme
Peter ClausenMD, PhD
Jens Schmidt IversenMD
Finn Thomsen NielsenMD
Marianne RixMD, PhD
Mette Brimnes DamholtMD, PhD
Researchers at Rigshospitalet and University of Copenhagen have shown that a particular gene variant lowers the risk of arteriosclerosis by 41 per cent, making the variant an obvious target for future drugs for cardiovascular disease treatment. The results are based on data from nearly 76,000 subjects and have just been published in the renowned New England Journal of Medicine.
Maxillofacial surgeons at the Department of Dental, Oral and Maxillofacial Surgery at Rigshospitalet lead the world in new operating techniques to help patients suffering with Horton's headache, a condition causing crippling pain. 60 patients with severe migraine or Horton's headache have undergone the operation. Nearly one in three are now almost completely free of pain and the majority have benefited from the operation. Many are now experiencing an entirely new family and work life following the procedure.
Ceremony for signing the Sister Institution agreement of the Global Academic Programs (GAP) between MD Anderson and Rigshospitalet